Vermund (1998) Recurrence after different primary treatment for cancer of the supraglottic larynx. Acta oncologica [0284-186X] 37(2):167–173Vermund H, Boysen M, Evensen JF, et al. Recurrence after different primary treatment for cancer of the supraglottic larynx. Acta Oncol 1998; 37: 167...
Second-line treatment options for patients with relapsed, extensive-stage small cell lung cancer (ES-SCLC) are limited, and even with currently available treatments, prognosis remains poor. Until recently, topotecan (a topoisomerase I inhibitor) was the only drug approved by the United States (US...
Stage I Cancer Patients (Before and after Surgery)One capsule two times a day (2 capsules daily) Stage II Cancer PatientsOne capsule three times a day (3 capsules daily) Prevention of Recurrence (Post Surgery)One capsule three times a day (3 capsules daily) ...
The cancer risk increases two to three times for people with a first-degree relative (parent or sibling) with colon cancer. The risk increases more if you have more than one affected family member, especially if the cancer was diagnosed at a young age. Other factors that may affect your ri...
cancer free and free from recurrence. With advancements in radiation, we can also treat left sided breast cancer and also preserve the heart causing no damage to it. Radiation is considered a boon for Head & Neck cancer patients who can bring their life back to normal with this advancemen...
--Question:After I have completed my treatments for breast cancer, should I follow any special diet to reduce the risk of recurrence? Answer: There's not a lot of research with the role of nutrition after a diagnosis and after treatment for breast cancer. There is some research going on ...
Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer. To assess the role of operation in the treatment and prevention of local recurrence in limited small cell lung cancer, we analyzed retrospectively 35 patie... FA Shepherd,RJ Ginsberg,WK...
aAn European Organisation for Research and Treatment of Cancer analysis of multicentre trials found significant interinstitutional variability in recurrence rates at first follow-up cystoscopy (RR-FFC) and attributed this to variable transurethral resection of bladder tumour (TURBT) quality. 正在翻译,请等...
A recent study reveals that some prostate cancer survivors have a persistent fear of cancer recurrence (FCR) even many years after diagnosis and treatment. Level of education, years since prostate removal, signs of cancer recurrence, and current therapie
Objective: This study is aimed to retrospectively evaluate and compare the efficacy and safety among topotecan, platinum-based rechallenge and other single agent therapies as second- line chemotherapy in patients with sensitive recurrent SCLC (small-cell lung cancer). Methods: Eighty- three patients wi...